Kumar Budur
Publications by Year
Research Areas
Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Attention Deficit Hyperactivity Disorder, Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments
Most-Cited Works
- → Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial(2022)177 cited
- → Tilavonemab in early Alzheimer’s disease: results from a phase 2, randomized, double-blind study(2023)121 cited
- → Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study(2023)93 cited
- → Correction: Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study(2023)1 cited
- → 0867 Effect of Pitolisant on Symptoms of Idiopathic Hypersomnia During an Open-Label Period in a Phase 3 Clinical Trial(2025)